Cargando…

Optical Imaging of Mesenchymal Epithelial Transition Factor (MET) for Enhanced Detection and Characterization of Primary and Metastatic Hepatic Tumors

Purpose: To assess optical imaging of Mesenchymal-Epithelial Transition factor (MET) for delineation and characterization of intrahepatic models of human hepatocellular carcinoma (HCC) and metastatic colorectal cancer (CRC), and thereby demonstrate its potential use in precision oncology. Materials...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esfahani, Shadi A., Heidari, Pedram, Kim, Sun A., Ogino, Shuji, Mahmood, Umar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039678/ https://www.ncbi.nlm.nih.gov/pubmed/27698938 http://dx.doi.org/10.7150/thno.15718

Ejemplares similares

A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling
por: Spooner-Harris, Madelyn, et al.
Publicado: (2022)

Optical Imaging with a Cathepsin B Activated Probe for the Enhanced Detection of Esophageal Adenocarcinoma by Dual Channel Fluorescent Upper GI Endoscopy
por: Habibollahi, Peiman, et al.
Publicado: (2012)

Endogenous Pancreatic Cancer Cell PD-1 Activates MET and Induces Epithelial-Mesenchymal Transition to Promote Cancer Progression
por: Harper, Megan M., et al.
Publicado: (2022)

Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling
por: Lee, Jin-Ku, et al.
Publicado: (2014)

Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer
por: Sylvester, Paul W
Publicado: (2014)

The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment
por: Demirkan, Binnaz
Publicado: (2013)

Acceleration of Mesenchymal-to-Epithelial Transition (MET) during Direct Reprogramming Using Natural Compounds
por: Seo, Ji-Hye, et al.
Publicado: (2022)

Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior
por: Savci-Heijink, C. D., et al.
Publicado: (2019)

Paracrine Met signaling triggers epithelial–mesenchymal transition in mammary luminal progenitors, affecting their fate
por: Di-Cicco, Amandine, et al.
Publicado: (2015)

Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
por: Yoshida, T, et al.
Publicado: (2014)

Modeling of mesenchymal hybrid epithelial state and phenotypic transitions in EMT and MET processes of cancer cells
por: He, Peng, et al.
Publicado: (2018)

Erratum to: Acceleration of Mesenchymal-to-Epithelial Transition (MET) during Direct Reprogramming Using Natural Compounds
por: Seo, Ji-Hye, et al.
Publicado: (2022)

KLF4 Induces Mesenchymal–Epithelial Transition (MET) by Suppressing Multiple EMT-Inducing Transcription Factors
por: Subbalakshmi, Ayalur Raghu, et al.
Publicado: (2021)

In primary airway epithelial cells, the unjamming transition is distinct from the epithelial-to-mesenchymal transition
por: Mitchel, Jennifer A., et al.
Publicado: (2020)

Emerging role of epithelial-mesenchymal transition in hepatic cancer
por: Yoshida, Go J.
Publicado: (2016)

MicroRNA-147 Induces a Mesenchymal-To-Epithelial Transition (MET) and Reverses EGFR Inhibitor Resistance
por: Lee, Chang Gong, et al.
Publicado: (2014)

Gefitinib Inhibits Invasive Phenotype and Epithelial-Mesenchymal Transition in Drug-Resistant NSCLC Cells with MET Amplification
por: La Monica, Silvia, et al.
Publicado: (2013)

Procaine Abrogates the Epithelial-Mesenchymal Transition Process through Modulating c-Met Phosphorylation in Hepatocellular Carcinoma
por: Yang, Min Hee, et al.
Publicado: (2022)

Actin Cytoskeleton Regulation of Epithelial Mesenchymal Transition in Metastatic Cancer Cells
por: Shankar, Jay, et al.
Publicado: (2015)

Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade
por: Luttman, Jillian Hattaway, et al.
Publicado: (2021)

SOX11 and Epithelial-Mesenchymal Transition in Metastatic Serous Ovarian Cancer
por: Psilopatis, Iason, et al.
Publicado: (2023)

Epithelial-Mesenchymal Transitions of Bile Duct Epithelial Cells in Primary Hepatolithiasis
por: Zhao, Lijin, et al.
Publicado: (2010)

The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells
por: Cheng, Yu, et al.
Publicado: (2018)

Gastrointestinal Carcinoma with Plasmacytoid Morphology: Positivity for c-MET, Arylsulfatase, and Markers of Epithelial-Mesenchymal Transition, as Indicators of Aggressivity
por: Kovacs, Zsolt, et al.
Publicado: (2019)

HGF/MET Regulated Epithelial-Mesenchymal Transitions And Metastasis By FOSL2 In Non-Small Cell Lung Cancer
por: Yin, Jun, et al.
Publicado: (2019)

High-level gain of mesenchymal-epithelial transition factor (MET) copy number using next-generation sequencing as a predictive biomarker for MET inhibitor efficacy
por: Wu, Shibo, et al.
Publicado: (2020)

Correction: Actin Cytoskeleton Regulation of Epithelial Mesenchymal Transition in Metastatic Cancer Cells
por: Shankar, Jay, et al.
Publicado: (2015)

Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells
por: Pan, Qin, et al.
Publicado: (2015)

LncRNA HOTAIR/miR‐613/c‐met axis modulated epithelial‐mesenchymal transition of retinoblastoma cells
por: Yang, Ge, et al.
Publicado: (2018)

Human telomerase reverse transcriptase promotes the epithelial to mesenchymal transition in lung cancer cells by enhancing c-MET upregulation
por: Prasad, Ram Raj, et al.
Publicado: (2021)

Design, Synthesis, and Evaluation of New Mesenchymal–Epithelial Transition Factor (c-Met) Kinase Inhibitors with Dual Chiral Centers
por: Yao, Han, et al.
Publicado: (2022)

Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis
por: Chou, Chuan-Kai, et al.
Publicado: (2016)

The Role of GLI in the Regulation of Hepatic Epithelial–Mesenchymal Transition in Biliary Atresia
por: Siyu, Pu, et al.
Publicado: (2022)

Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells
por: Clement, Michelle Simone, et al.
Publicado: (2020)

MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells
por: Jakobsen, K R, et al.
Publicado: (2017)

Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells
por: NAGAHARA, TERUYA, et al.
Publicado: (2015)

FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells
por: Yang, Hui, et al.
Publicado: (2015)

Metastatic ability and the epithelial‐mesenchymal transition in induced cancer stem‐like hepatoma cells
por: Nishiyama, Mitsuo, et al.
Publicado: (2018)

OLFM4 Inhibits Epithelial–Mesenchymal Transition and Metastatic Potential of Cervical Cancer Cells
por: Li, Juan, et al.
Publicado: (2019)

Epigenetic Regulation of Epithelial to Mesenchymal Transition in the Cancer Metastatic Cascade: Implications for Cancer Therapy
por: Liu, Qiu-Luo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1j89rakd8qbpifnlfp7n2ofbrg